Faleiro-Rodrigues et al: Loss of ! catenin expression in primary ovarian carcinomas Takayama T, Shiozaki H, Shibamoto S, Oka H, Kimura Y, Tamura S, Inoue M, Monden T, Ito F, Monden M (1996) !catenin expression in human cancers. Am J Pathol 148, 3946. Tanaka M, Kitajima Y, Edakuni G, Sato S, Miyazaki K (2002) Abnormal expression of E-cadherin and !-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Br J Surgery 89, 236-244. Tsukita S, Tsukita S, Nagafuchi A, Yonemura S (1992) Molecular linkage between cadherins and actin filaments in cell-cell adherens junctions. Curr Opin Cell Biol 4, 834839. Ueda M, Gemmill RM, West J, Winn R, Sugita M, Tanaka N, Ueki M, Drabkin HA (2001) Mutations of the !- and #catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 85, 64-68. Van Aken E, De Wever O, Correia da Rocha AS, Mareel M (2001) Defective E-cadherin/catenincomplexes in human cancer. Virchows Archn 439, 725-751. Vermeulen SJ, Bruyneel EA, Bracke ME, De Bruyne GK, Vennekens KM, Vleminckx KL, Berx GJ, van Roy FM, Mareel MM (1995) Transition from the noninvasive to the invasive phenotype and loss of !-catenin in human colon cancer cells. Cancer Res 55, 4722-4728.
Vleiminckx K, Vakaet l Jr, Mareel M, Fiers W, Van Roy F (1991) Genetic manipulation of E-Cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66, 107-119.
Cristina Faleiro-Rodrigues
184